https://www.selleckchem.com/products/erastin.html
ctive anxiety (42.52±0.05), trait anxiety (42.23±0.07) and depressive disorders (51.41±0.07). It is proved that the treatment of emotional disturbances of the anxiety-depressive spectrum lead to a significant levelling in existing psychological changes.The deterioration of the existing emotional disorders of the anxiety-depressive spectrum among patients at risk in the absence of drug treatment has been established.The goal is to develop and evaluate the effectiveness of a psychoeducational program (PP) aimed at timely detection, preven